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Summary
Rationale:  Epilepsy  is  among  the  most  common  neurological  disorders  worldwide.  However,
there are  few  large,  population-based  studies  of  the  prevalence  and  risk  factors  for  epilepsy  in
southern Africa.
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Methods:  From  August  2008  to  February  2009,  as  part  of  a  multi-site  study,  we  undertook  a  three-
stage, population-based  study,  embedded  within  the  Agincourt  health  and  socio-demographic
surveillance  system,  to  estimate  the  prevalence  and  identify  risk  factors  of  active  convulsive
epilepsy (ACE)  in  a  rural  South  African  population.
Results:  The  crude  prevalence  of  ACE,  after  adjusting  for  non-response  and  the  sensitivity  of  the
screening method,  was  7.0/1,000  individuals  (95%CI  6.4—7.6)  with  signiﬁcant  geographic  hetero-
geneity across  the  study  area.  Being  male  (OR  =  2.3;  95%CI  1.6—3.2),  family  history  of  seizures
(OR =  4.0;  95%CI  2.0—8.1),  a  sibling  with  seizures  (OR  =  7.0;  95%CI  1.6—31.7),  problems  after  deliv-
ery (OR  =  5.9;  95%CI  1.2—24.6),  and  history  of  snoring  (OR  =  6.5;  95%CI  4.5—9.5)  were  signiﬁcantly
associated  with  ACE.  For  children,  their  mother’s  exposure  to  some  formal  schooling  was  pro-
tective (OR  =  0.30;  95%CI  0.11—0.84)  after  controlling  for  age  and  sex.  Human  immunodeﬁciency
virus was  not  found  to  be  associated  with  ACE.
Conclusions:  ACE  is  less  frequent  in  this  part  of  rural  South  Africa  than  other  parts  of  sub-Saharan
Africa. Improving  obstetric  services  could  prevent  epilepsy.  The  relationship  between  snoring  and
ACE requires  further  investigation,  as  does  the  relative  contribution  of  genetic  and  environmental
factors  to  examine  the  increased  risk  in  those  with  a  family  history  of  epilepsy.
Case-control;
Risk factors;
Population-based
©  2014  Elsevier  B.V.  All  rights  reserved.
Introduction
Epilepsy  is  one  of  the  most  common  neurological  disorders
in  the  world,  affecting  about  69  million  people  worldwide,
with  90  percent  living  in  low-  and  middle-income  countries
(LMICs)  (Ngugi  et  al.,  2010).  It  contributes  nearly  one  per-
cent  to  the  global  burden  of  disease  (Murray  et  al.,  2012),
and  20  percent  of  the  global  burden  of  epilepsy  is  in  Africa
(World  Health  Organization,  2004).
While  these  ﬁgures  suggest  a  large  burden  of  epilepsy  in
Africa,  they  are  derived  from  a  limited  number  of  studies
that  employ  different  case  deﬁnitions  and  methodologies.
Studies  suggest  that  utilizing  hospital  records  in  LMICs
to  detect  epilepsy  under-estimates  the  prevalence  by  at
least  80  percent  due  to  limited  health  care  utilization  by
people  with  epilepsy  (PWE)  in  these  settings  (Osuntokun
et  al.,  1987).  Thus,  population-based  surveys  are  frequently
used  to  estimate  prevalence,  though  not  without  limita-
tions,  including  the  absence  of  well-demarcated  populations
and  vital  statistics  registries.  This  limitation,  coupled  with
the  lack  of  trained  medical  personnel  available  to  make
the  diagnosis  of  epilepsy,  makes  estimating  the  burden  of
epilepsy  in  sub-Saharan  Africa  unusually  challenging.
A  recent  systematic  review  and  meta-analysis  high-
lighted  the  signiﬁcant  variation  in  the  prevalence  of  epilepsy
between  high-income  countries  and  LMICs,  with  a  higher
prevalence  in  LMICs,  especially  in  rural  settings  (Ngugi  et  al.,
2010).  The  authors  suggest  that  study  size  and  the  economic
development  level  of  the  study  country  largely  explain
the  heterogeneity,  although  increases  in  obstetric  injury,
head  injuries,  and  infections  and  infestations  of  the  cen-
tral  nervous  system  (CNS)  (Newton  &  Garcia,  2012),  such
as  toxoplasmosis  and  toxocara  (Wagner  &  Newton,  2009),
malaria  (Carter  et  al.,  2004)  and  human  immunodeﬁciency
virus  (HIV)  are  thought  to  contribute  (Ngugi  et  al.,  2010),  but
there  is  little  data  from  South  Africa  where  the  prevalence
of  HIV  is  very  high.
As  part  of  a  multi-centre  study  on  the  epidemiology  of
epilepsy  in  demographic  sites  (SEEDS)  (Ngugi  et  al.,  2013),
we  conducted  a  three-stage,  population-based  survey  and  a
case-control  study  to  determine  the  prevalence  of  and  risk
factors  for  active  convulsive  epilepsy  (ACE)  in  rural  South
Africa.  In  particular,  we  were  interested  in  examining  the
risk  factors  for  ACE  in  a non-malaria  endemic  area,  particu-
larly  HIV  since  it  has  a  high  prevalence  in  South  Africa.
Methodology
Population  and  study  area
The  study  was  conducted  in  the  rural  Agincourt  health
sub-district,  in  which  the  Agincourt  health  and  socio-
demographic  surveillance  system  (HDSS)  operates  and  is
located  500  kilometers  northeast  of  Johannesburg  (Fig.  1).
The  Agincourt  HDSS  was  established  in  1992  as  a research
platform  to  inform  health  and  development  policy  through
evidence-based  research  (Kahn  et  al.,  2012).  The  pop-
ulation  has  been  enumerated  through  an  annual  census
update,  following  baseline  measurement  in  1992  and  cap-
tures  vital  statistics  including  births,  deaths,  and  in-  and
out-migrations.
In  2008,  the  population  was  83,121  individuals  in  15,841
households  and  25  villages  on  420  km2 of  semi-arid  scrub-
land.  The  site  forms  part  of  a  former  bantustan,  or  ethnic
‘homeland’  implemented  during  the  Apartheid  era.  The  pop-
ulation  is  mainly  Xi-Tsonga  speaking,  with  one-third  (32.8%)
originally  from  Mozambique.
The  leading  causes  of  death  ascertained  through  the
Agincourt  HDSS  are  HIV/AIDS,  cardiovascular  disease  and
trauma  (road  trafﬁc  accidents,  assaults)  (Tollman  et  al.,
2008).  Six  government  clinics,  one  larger  government  health
centre,  and  one  public-private  community  health  centre,
with  its  main  focus  being  HIV  and  tuberculosis,  provide  pri-
mary  health  care  services  for  the  population.  Referrals  are
to  three  government  district  hospitals  located  25  to  55  km
from  the  sub-district.
Ethics
Ethical  clearance  for  the  study  was  received  from  the
Human  Research  Ethics  Committee  of  the  University  of  the
Witwatersrand,  Johannesburg,  South  Africa  (Clearance  num-
ber:  M080455)  and  the  Mpumalanga  Province  Department  of
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Figure  1  Map  of  South  Africa,  Bushbuckridge  Municipality,  and  the  Agincourt  sub-district  and  health  and  socio-demographic
surveillance  system,  2008.
Health’s  Research  and  Ethics  committee.  Written  informed
consent  was  sought  from  each  participant  in  the  study.
Parental  or  guardian  informed  consent  was  sought  in  the
case  of  children  or  patients  with  cognitive  impairment,  with
verbal  assent  being  sought  from  children  and  cognitively
impaired  patients.
Case  deﬁnition  of  active  convulsive  epilepsy  (ACE)
We  identiﬁed  patients  with  Active  convulsive  epilepsy  (ACE)
since  convulsive  epilepsies  are  associated  with  increased
morbidity,  mortality  (Diop  et  al.,  2005)  and  greater
social  stigma  than  non-convulsive  epilepsies  (World  Health
Organization,  2005).  ACE  was  deﬁned  as  having  two  or
more  unprovoked  convulsive  seizures  occurring  more  than
24  hours  apart,  with  at  least  one  seizure  occurring  in  the
12  months  preceding  the  study  or  currently  taking  anti-
epileptic  drugs  (AEDs)  (Edwards  et  al.,  2008).
Procedures
Between  August  and  November  2008,  two  questions  (‘Do  you
have  ﬁts  or  has  someone  ever  told  you  that  you  have  ﬁts?’
and  ‘Do  you  experience  episodes  in  which  you  legs  or  arms
have  jerking  movements  or  fall  to  the  ground  and  lose  con-
sciousness?’),  used  previously  in  a  similar  study  (Edwards
et  al.,  2008),  were  administered  by  census  ﬁeldworkers  to
a  senior  member  of  each  household  (n  =  15,841)  on  behalf
of  each  member  of  the  household.  The  questions  had  been
piloted  previously  in  the  local  language  (Xi-Tsonga)  at  a  dis-
trict  hospital  and  had  a  high  speciﬁcity  (100%)  and  sensitivity
(98%).  The  questions  were  included  in  the  2008  annual  Agin-
court  HDSS  census  update  round.  The  two  questions  within
the  census  update  constituted  Stage  I  of  the  study  and  sought
to  identify  all  people  who  had  experienced  a  seizure  prior
to  1  August  2008  (the  prevalence  day).
In  Stage  II  (August—December  2008),  trained  ﬁeldworkers
visited  all  individuals  who  responded  ‘yes’  to  either  of  the
two  questions  in  Stage  I  and  asked  a  detailed  questionnaire,
based  on  previous  studies  (Placencia  et  al.,  1992),  about
the  characteristics  and  history  of  the  seizures.  Fieldworkers
were  speciﬁcally  trained  by  the  study  managers  (RGW,  AKN)
and  study  neurologist  (CRN)  on  the  administration  of  this
questionnaire.  Individuals  who  had  experienced  at  least  two
seizures  in  their  lifetime  and  at  least  one  seizure  with  abnor-
mal  movement  (aimed  at  identifying  convulsive  epilepsy)
in  the  preceding  12  months  or  currently  taking  AEDs  were
invited  for  further  assessment  in  the  epilepsy  clinic  within
the  following  week  (Stage  III).
In  Stage  III  (September  2008—February  2009),  socio-
demographic  information  was  obtained  and  a  specially
trained  nurse  made  the  diagnosis  of  ACE,  based  on  a  positive
clinical  history  provided  by  the  patient’s  caregiver  or  family
member.  A  clinical  examination  was  completed  to  iden-
tify  neurological  abnormalities  and  physical  co-morbidities.
Blood  was  drawn  from  each  patient  for  serological  testing.
A  neurologist  (CRN)  conﬁrmed  the  diagnosis  of  epilepsy  by
reviewing  all  of  the  patient  records  and  examining  selected
patients.
Population  sample
In  addition  to  identifying  cases  of  epilepsy  through  the
population  screen  (Stage  I),  a  random  sample  of  4,500  indi-
viduals  (all  ages  and  both  sexes),  from  the  Agincourt  HDSS,
were  screened  with  the  Stage  II  tool.  This  population  sam-
ple  simulated  the  traditional  two-stage  epilepsy  prevalence
study  design  (Placencia  et  al.,  1992)  and  was  used  to  eval-
uate  the  three-stage  methodology  of  this  study.  Those  who
screened  positive  were  referred  for  assessment  in  Stage  III
and  included  as  cases  in  the  case-control  study.
Furthermore,  individuals  who  were  referred  to  the
epilepsy  clinic  by  sources  (clinic  staff  and  community
leaders)  other  than  the  three-stage  study  were  clinically
assessed  and  those  found  to  have  ACE  were  included  as  cases
in  the  case-control  study.
Selection  of  controls  for  case  control  study
Controls  were  selected  randomly  from  those  that  screened
negative  for  epilepsy  in  the  population  sample  and  fre-
quency  matched  to  cases  diagnosed  with  ACE  during  Stage
III  of  the  study  (on  age-bands  0—5,  6—12,  13—18,  19—28,
29—49,  and  50+  years).  If  the  selected  control  was  not  found
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Table  1  Crude  and  adjusted  prevalence  of  ACE  by  age  and  sex,  Agincourt  sub-district,  South  Africa  2008.
Age  band  Cases  of  ACE  Crude
prevalence
95%  Conﬁdence
interval
Adjusted
prevalence
95%  Conﬁdence
interval
0  to  5  years  10  0.87  0.33—1.41  2.18  0.88—3.48
6 to  12  years  29  2.23  1.42—3.03  4.79  3.09—6.52
13 to  18  years  34  2.76  1.83—3.68  6.38  4.32—8.42
19 to  28  years  47  2.65  1.89—3.40  6.23  4.47—7.98
29 to  49  years  87  4.70  3.71—5.69  10.95  8.74—13.13
50+ years  38  3.94  2.68—5.19  9.55  6.69—12.41
Male 129  3.24  2.68—3.80  7.43  5.53—7.82
Female 116  2.69 2.20—3.18 6.50 4.53—6.54
after  three  attempted  visits,  another  control  was  selected
randomly  as  a  replacement.  For  each  control  selected,  a
clinical  history  and  blood  sample  were  taken  and  a  clinical
examination  performed.
Serological  testing
Blood  from  cases  and  controls  was  collected  in  Stage  III  of  the
study  and  exposure  to  Toxocara  canis  excretory-secretory
antigen  with  a  sensitivity  of  97.1%  and  speciﬁcity  of  78.6%
(Noordin  et  al.,  2005),  toxoplasmosis  (Toxoplasma  IgG  ELISA
Kit,  Genesis  Diagnostics  Ltd,  Product  Code  GD80  (Liesenfeld
et  al.,  1996)),  and  Plasmodium  falciparum  IgG  antibodies
tested  by  ELISA  was  examined.  Exposure  to  the  larval  stage
(cysticercosis)  and  adult  stage  (taeniasis)  of  the  parasite
T.  solium  in  the  patients  only,  given  the  absence  of  cys-
ticersosis  reported  by  the  local  radiologists.  HIV  antibodies
(Vironostika  HIV  Uni-form  II  Ag/Ab  Kit)  were  also  measured
after  written  informed  consent  was  received  from  each  indi-
vidual  or  their  legal  guardian.
Statistical  analysis
Data  were  double  entered  into  a  mySQL  database  (Ora-
cleCorp,  Redwood  Shores,  CA,  USA).  All  analyses  were
conducted  using  Stata  10  (StataCorp,  College  Station,  TX,
USA).
We  adjusted  for  attrition  between  the  stages  of  the  sur-
vey  using  a  multiple  imputation  method.  The  ﬁgures  were
also  adjusted  for  the  sensitivity  of  the  three-stage  method,
previously  calculated  in  a  separate  study  (Ngugi  et  al.,  2012)
(Table  1).  We  report  adjusted  prevalence  by  age,  sex,  and
village  of  residence.  We  also  present  prevalence  estimates
standardized  to  the  2000  US  population  (US  Census  Bureau,
2000)  to  allow  for  global  comparison  and  the  median  and
interquartile  range  of  age  of  onset  of  ACE.  Finally,  we  report
the  adjusted  prevalence  ﬁgures  from  the  population  sample
of  4,500  individuals.
Factors  associated  with  active  convulsive  epilepsy
In  the  case-control  study,  we  performed  analysis  on  20
socio-demographic  and  clinical  variables  and  four  serolog-
ical  variables  (Table  3).  We  developed  models  using  logistic
regression  and  in  each  model  included  a  variable  of  interest,
adjusted  for  age  and  sex.  In  patients  >18  years  of  age,
variables  on  whether  alcohol  was  consumed  and  period
of  consumption  were  analyzed.  Three  additional  variables
were  analyzed  for  patients  <18  years  old:  mother’s  mari-
tal  status,  whether  the  mother  experienced  some  formal
education,  and  her  level  of  education.
Results
Participation  in  the  three-stages  of  the  survey  is  displayed
in  Fig.  2.
Table  2  Adjusted  prevalence  of  active  convulsive  epilepsy
by village  of  residence,  Agincourt  sub-district,  2008.
Villagea Cases  of  ACE Adjusted
prevalence
95%  Conﬁdence
interval
A  7  7.17 5.36—9.40
B 3  2.77  1.26—5.25
C 20  6.21 4.30—8.67
D 22  10.92 7.78—14.90
E 6  6.31 3.74—9.96
F 11  5.46  3.34—8.42
G 9  7.24  4.22—11.57
H 13  4.67  2.99—6.84
I 1  6.84  4.68—9.65
J 2  5.1  3.27—7.58
K 11  7.39  5.49—9.73
L 3  3.02  1.12—6.21
M 6  3.02  1.21—6.21
N 1  6.77  4.30—10.14
O 6  11.41  7.07—17.38
P 10  8.45  5.53—12.35
Q 7  10.04  7.25—13.55
R 17  14.98  10.06—21.45
S 18  6.64  2.67—13.62
T 11  3.03  0.06—8.83
U 16  9.91  5.67—16.04
V 10  7.2  5.24—9.66
W 4  7.07  4.05—11.46
X 10  9.96  6.17—15.18
Y 21  1.77  0.21—6.28
Overall  245  7.01  6.23—7.78
a Villages have been anonymized due to small village size and
conﬁdentiality of individuals with ACE.
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Stage 1
Stage 2
Stage 3
n=82,818 (99.64%)
Eligible Population (2008 Agincourt Census)     
n=83,121
Deceased; n=45
Not found; n=258
 Screened in Stage 1    
Positive;             
n= 546 (0.66%) Population Sample           
n= 4500Unwilling; n=4
Not found; n=27
Screened in Stage 2     
n= 515 (94.23%) Found; n= 3889 (91.44%)
Positive ;             
n= 354 (68.74%)
Positive ; n= 67 (1.72%)  
(38 also found positive in Stage 1)
Matched Controls        
n= 262 (90.34%)
Unwilling; n=4 Self-referred; found positi ve 
at various Stages Not found; n=27
Assessed in Stage 3     
n= 328 (92.66%)
Assessed in Stage 3      
n= 58 (86.57%) Assessed; n= 262 (100%) Positive (ACE)          
n= 56                   
(33 screen negative in Stage 1)  
Positive (ACE)         
n= 245 (74.70%)
Positive (ACE)          
n= 26 (44.83%)          
(16 screened positive in Stage 1)  
Figure  2  Study  design  schema  and  numbers  of  individuals  at  each  stage,  2008.
Prevalence
We  identiﬁed  245  cases  of  ACE  in  the  three-stage  study.
The  unadjusted  prevalence  of  ACE  was  3.0/1,000  individuals
(95%CI:  2.6—3.3)  within  the  three-stage  study.  Adjusting  for
attrition  and  the  sensitivity  of  the  three-stage  methodol-
ogy  (48.6%),  the  adjusted  crude  prevalence  was  7.0/1,000
(95%CI:  6.4—7.6).  The  sensitivity  of  48.6%  for  the  three-
stage  methodology  was  derived  from  a  validation  study
performed  in  Kenya  using  clinical  assessments  as  the  gold
standard  (Ngugi  et  al.,  2012).  The  prevalence,  standard-
ized  to  the  age  distribution  of  the  US  population  in  2000
and  adjusted  for  attrition  and  sensitivity  of  the  three-stage
method,  was  8.1/1,000  individuals  (95%CI:  7.5—8.7).
Within  the  population  sample  of  3,889  (611  not  found  due
to  permanent  out-migration  from  the  study  area)  the  crude
prevalence  was  6.7/1,000  individuals  (95%CI:  4.1—9.3),
while  the  adjusted  prevalence  (adjusting  for  attrition  and
sensitivity  (76.7%)  of  the  two-stage  method  against  the  gold
standard  (Ngugi  et  al.,  2012))  was  9.8/1,000  individuals  (95%
CI:  6.9—13.4).
The  adjusted  prevalence  of  ACE  by  village  ranged  from
1.8—15.0/1,000  individuals  (Table  2)  and  this  variation  was
statistically  signiﬁcant  (p  =  0.05),  although  the  response  rate
for  Stage  1  and  Stage  2  did  not  vary  between  villages.
Age  of  onset  of  epilepsy
239  individuals  reported  age  of  onset  of  their  seizures.
The  distribution  of  age  of  onset  was  left-skewed  with  7.1%
(n  =  17)  experiencing  seizures  within  the  ﬁrst  year  of  life
(Fig.  3)  and  30.8%  (n  =  74)  before  5  years.  The  median  age
at  onset  was  12  years  interquartile  range  was  0—23  years.
Factors  associated  with  epilepsy
Of  the  311  cases  of  ACE  identiﬁed  (245  from  the  three-stage
survey,  10  additional  cases  from  the  population  sample,  and
56  cases  referred  from  other  sources),  292  cases  (94%)  were
matched  to  260  controls.  The  matching  was  not  1:1  due  to
a  high  proportion  of  refusals  in  the  controls.
Univariate  analysis
Within  the  univariate  analysis,  male  sex,  family  history  of
seizures,  a  sibling  with  seizures,  problems  after  delivery,  loss
of  consciousness  during  head  injury  and  history  of  snoring  at
least  three  nights  per  week  were  associated  with  ACE.  ACE
was  not  associated  with  exposure  to  any  of  the  parasites
tested  and  none  of  the  cases  had  antibodies  to  T.  solium.
For  individuals  >18  years,  neither  alcohol  consumption
nor  length  of  alcohol  consumption  was  associated  with
ACE.
For  individuals  <18  years,  having  a  mother  with  some
history  of  formal  education  reduced  her  child’s  risk  of
ACE  (OR  =  0.34;  95%CI  0.12—0.94),  while  history  of  snor-
ing  at  least  three  nights  per  week  (OR  =  6.51;  95%CI
3.25—13.06)  was  associated  with  an  increased  prevalence
of  ACE.  Neither  the  mother’s  level  of  formal  education  nor
mother’s  marital  status  were  signiﬁcantly  associated  with
ACE.
Multivariate  modeling
After  controlling  for  age  and  sex,  a  family  member  with
seizures,  a  sibling  with  seizures,  problems  after  delivery,
and  history  of  snoring  at  least  three  nights  per  week  were
associated  with  ACE  (Table  3).
Additionally,  for  individuals  <18  years,  a mother  with  for-
mal  education  (OR  =  0.30;  95%CI  0.11—0.84)  was  found  to  be
protective.
While  head  injury  was  not  associated  with  ACE  in  the  mul-
tivariate  model,  males  were  twice  as  likely  to  experience
head  injury  (OR  =  2.01;  95%CI  1.06—3.88)  when  compared
with  females.
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Table  3  Multivariate  analysis  of  possible  risk  factors  associated  with  active  convulsive  epilepsy,  Agincourt  sub-district,  2008.
Variable  of  interest  Controls  (n  =  260)  Cases  (n  =  292)  Odds  ratio  (95%  CI)a p-value
Sex
Female  176  (67)  142  (49)  1
Male 85  (33)  150  (51)  2.27  (1.60—3.23)  <0.001
Family history  of  non-febrile  seizures
Someone  in  family  with  seizures  11  (4)  41  (14)  4.01  (1.99—8.09)  <0.001
Someone in  family  with  past  history  of  seizure  0  (0)  12  (4) b <0.001
Mother with  Seizures  0  (0)  3  (1) b 0.146
Father with  seizures 1  (0)  2  (1)  1.87  (0.16—21.7)  0.615
Sibling with  seizure 2  (1) 14  (5) 7.05  (1.57—31.68) 0.011
Location of  birth
Hospital  9  (5) 17  (6) 1
Clinic 109  (62)  144  (54)  0.68  (0.29—1.60)  0.379
Home 57  (32)  97  (36)  0.66  (0.26—1.66)  0.379
Unknown 2  (1)  8  (3)  1.58  (0.267—9.38)  0.612
Adverse perinatal  events
Normal  delivery  163  (96)  246  (93)  1
Abnormal delivery  7  (4)  19  (7)  2.05  (0.81—5.15)  0.128
No problems  after  delivery  174  (99)  249  (94)  1
Problems after  delivery  2  (1)  14  (5)  5.93  (1.18—24.58)  0.030
History of  febrile  seizures  0  (0)  3  (1) b 0.101
History of  head  trauma
No  history  of  head  injury  245  (94)  260  (89)  1
History of  head  injury  16  (6)  31  (11)  1.57  (0.82—2.99)  0.170
Loss of  consciousness  with  the  head  injury 3  (19)  20  (65)  2.69  (0.68—10.61)  0.157
Sociodemographic  and  clinical  characteristics
Abnormal  skull  shape  0  (0)  23  (8) b <0.001
History of  eating  cassava  154  (59)  190  (66)  1.31  (0.92—1.88)  0.137
History of  eating  pork 69  (26)  59  (20)  0.70  (0.47—1.04)  0.078
History of  eating  soil 19  (7) 18  (6)  1.05  (0.53—2.08)  0.878
History of  dogs  in  dwelling 52  (20)  68  (23)  1.17  (0.77—1.77)  0.457
History of  cats  in  dwelling 22  (8) 16  (6)  0.64  (0.33—1.27)  0.202
History of  snoring  (at  least  3x/week) 51  (20) 187  (64) 6.51  (4.45—9.53)  <0.001
Serological variables
Positive  for  malarial  antibodies 71  (33) 78  (39) 1.16  (0.76—1.78)  0.485
Positive for  HIV  antibodies  49  (23)  36  (18)  0.73  (0.44—1.21)  0.226
Toxocara 77  (36)  73  (37)  1.17  (0.78—1.79)  0.444
Toxoplasmosis  22  (10)  27  (14)  1.20  (0.64—2.25)  0.580
n (%)
a Odd Ratios adjusted for age and sex.
b Indicates that an Odds ratio could not be calculated due to zero exposure in the control population.
Discussion
From  this  community-based  research  in  rural  northeast
South  Africa,  we  found  the  prevalence  of  epilepsy  in  a
rigorous  three-stage  study  to  be  lower  than  that  reported
elsewhere  in  sub-Saharan  Africa  (SSA).  After  adjusting  for
the  sensitivity  of  the  screening  tool  and  attrition  in  the  three
stage  survey,  our  ﬁndings  remain  lower  than  the  12.7/1,000
cases  of  active  epilepsy  reported  in  a  meta-analysis  of
studies  in  rural  areas  of  LMICs  (Ngugi  et  al.,  2010)  and
other  SEEDS  sites  in  SSA  (Ngugi  et  al.,  2013).  This  could
be  explained  by  differences  in  methodology  or  risk  factors
(Ngugi  et  al.,  2013).  ACE  may  only  constitute  25%  of  all
epilepsies  (Cockerell  et  al.,  1995;  Edwards  et  al.,  2008).
In  high-income  countries,  only  half  of  the  epilepsies  are
convulsive  and  about  half  of  patients  with  convulsive
epilepsy  experienced  a  seizure  within  the  last  year
(Cockerell  et  al.,  1995).  Therefore,  the  real  prevalence  of
active  epilepsy  may  well  be  higher  than  the  adjusted,  age-
standardized  prevalence  found  in  this  study  (8.1/1,000).
Furthermore,  the  increased  mortality  associated  with
epilepsy  in  Africa  (Diop  et  al.,  2005)  and  the  higher  rates  of
spontaneous  remission  (Newton  &  Garcia,  2012)  may  lower
the  prevalence  of  active  epilepsy.  We  suspect  the  lower
unadjusted  prevalence  ﬁgure  recorded  in  the  three-stage
study  may  also  be  the  result  of  social  stigma.  A  recent  study
from  Kenya  found  that  false  negative  individuals  in  a  sim-
ilar  three-stage  study  reported  higher  stigma  scores  on  a
validated  stigma  scale  than  those  positively  identiﬁed  in
Stage  I  (Ngugi  et  al.,  2012).  While  stigma  levels  are  likely
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Figure  3  Age  of  onset  (bars)  and  prevalence  with  95%  conﬁdence  intervals  (by  5-year  age  bands)  of  active  convulsive  epilepsy,
Agincourt sub-district,  2008.
to  vary  depending  on  social  perceptions  of  epilepsy,  further
research  is  needed  to  deﬁne  the  extent  of  under-reporting.
Prevalence  by  sex
Epilepsy  studies  from  SSA  report  varying  levels  of  prevalence
by  sex  (Birbeck  &  Kalichi,  2004).  Our  data  suggest  that  males
are  more  likely  to  develop  epilepsy  than  females  during  the
ﬁrst  two  decades  of  life,  perhaps  due  to  risk  factor  patterns
discussed  below.
Age  of  onset
These  ﬁndings  from  rural  South  Africa  replicate  those  found
in  Tanzania  and  Ethiopia  as  well  as  the  other  SEEDS  sites
(Kenya,  Tanzania,  Uganda  and  Ghana),  which  suggest  that
the  highest  incidence  of  epilepsy  occurs  in  the  ﬁrst  decade  of
life  (Rwiza  et  al.,  2005;  Tekle-Haimanot  et  al.,  1997;  Ngugi
et  al.,  2013).  We  found  the  onset  of  epilepsy  to  be  greatest  in
the  ﬁrst  year  of  life,  which  is  supported  by  our  case-control
data  in  which  problems  after  delivery  were  associated  with
ACE.  Underlying  genetic  or  congenital  abnormalities  could
possibly  be  important  causes  of  epilepsy  in  this  community.
The  second  peak  of  onset  during  adolescence  (10—15  years)
may  be  indicative  of  environmental,  infectious  and  trau-
matic  risk  factors.  The  increased  onset  during  the  fourth
decade  of  life  (30—39  years)  may  reﬂect  the  bimodal  dis-
tribution  of  epilepsy  seen  in  high-income  countries  (World
Health  Organization,  2005).  South  Africa  is  experiencing
increasing  levels  of  cardiovascular  disease  (Mayosi  et  al.,
2009),  which  may  increase  the  incidence  of  epilepsy  later
in  life,  although  this  tends  to  occur  at  younger  age  in  popu-
lations  undergoing  epidemiological  transition  than  in  high
income  populations  (Connor  et  al.,  2007).  Further  research  is
needed  to  determine  the  underlying  causes  of  symptomatic
epilepsy  in  rural  South  Africa.
Prevalence  by  village  of  residence
There  are  a  number  of  possible  reasons  for  the  inter-village
heterogeneity  of  the  prevalence  of  ACE  across  the  Agin-
court  sub-district.  While  attrition  of  respondents  between
stages  did  not  vary  signiﬁcantly  by  village,  it  is  possible
that  under-reporting  of  convulsions  in  Stage  I (suggested
by  10  false-negatives  in  the  population  sample)  contributed
to  the  observed  village-level  heterogeneity.  Differences  in
response  rates  and  awareness  of  epilepsy  have  been  high-
lighted  as  possible  causes  of  heterogeneity  in  small  areas
(Edwards  et  al.,  2008).
Genetic  abnormalities,  exposure  to  a  particular  environ-
mental  risk  factor,  or  access  to  health  facilities  (in  terms
of  perinatal  care)  may  also  contribute  to  the  heterogene-
ity,  as  we  identiﬁed  several  households  with  more  than  one
person  with  epilepsy.  Ultimately,  however,  it  is  possible  that
the  heterogeneity  is  due  to  combination  of  factors  or  may
reﬂect  the  actual  distribution  of  epilepsy  in  a  rural  South
African  setting.
Factors  associated  with  ACE
The  factors  associated  with  ACE  were  different  in  Agincourt
compared  to  other  SEEDS  sites  (Ngugi  et  al.,  2013).
Sex
We  found  a  higher  prevalence  in  males  than  in  females,
which  replicates  other  studies  from  SSA  (Preux  &  Druet-
Cabanac,  2005).  Being  male  may  put  an  individual  at  greater
risk  for  known  risk  factors,  such  as  head  injury.  Within
this  study,  males  with  epilepsy  were  twice  as  likely  to
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have  experienced  a  head  injury  than  females  with  epilepsy.
Road  trafﬁc  accidents  and  assault—both  common  causes
of  traumatic  brain  injury  and  potential  risk  factors  for
epilepsy—were  found  to  be  leading  causes  of  death  in
individuals  aged  15—49  years  within  the  Agincourt  sub-
district  (Tollman  et  al.,  2008).  Furthermore,  it  has  also  been
reported  that  females  are  more  likely  to  hide  their  epilepsy
(Preux  &  Druet-Cabanac,  2005),  which  may  contribute  to  the
higher  prevalence  observed  in  males.
Family  history  of  seizures
A  family  history  of  seizures  was  shown  to  be  a  signiﬁcant  risk
factor  for  developing  convulsive  epilepsy  in  this  study,  as  in
other  studies  from  SSA  (Edwards  et  al.,  2008;  Matuja  et  al.,
2001;  Nsengiyumva  et  al.,  2003).  Small  numbers  in  our  study
limited  exploration  of  relationships  between  family  mem-
bers  experiencing  seizures;  however,  this  study  did  ﬁnd  that
having  a  sibling  with  seizures  is  a  signiﬁcant  risk  factor  for
epilepsy.  Further  research  could  explore  these  relationships
and  the  underlying  etiology  to  assess  the  balance  between
genetic,  social  and  environmental  exposures.  The  large  and
closely  related  family  samples  in  much  of  rural  SSA  could
support  expanded  research  into  genetic  risk  factors  for  ACE
(Farnarier  &  Genton,  1996).
Adverse  perinatal  events
Problems  after  delivery  were  found  to  be  a  risk  factor  for
developing  epilepsy,  while  problems  during  delivery  do  not
appear  to  be  a  risk  factor.  Studies  from  Tanzania  and  Burundi
found  the  risk  of  developing  ACE  to  be  4.5  and  1.9  times
greater,  respectively,  after  perinatal  complications  (Matuja
et  al.,  2001;  Nsengiyumva  et  al.,  2003).  In  the  current  study,
at  least  60%  of  births  occurred  at  clinics  or  hospitals.  In  this
regard,  rural  South  Africa  may  differ  from  the  rest  of  SSA
where  most  children  are  born  at  home  without  professional
support  (Diop  et  al.,  2003).
Snoring
Snoring  was  included  to  detect  sleep  disturbance  in  peo-
ple  with  epilepsy,  as  documented  elsewhere  (Van  Golde
et  al.,  2011).  We  found  that  snoring  was  signiﬁcantly  associ-
ated  with  ACE,  though  snoring  was  not  associated  with  body
mass  index,  age  or  sex.  Snoring  is  a  symptom  in  obstructive
sleep  apnea  (OSA)  (American  Sleep  Disorders  Association,
2001)  and  a  number  of  studies  have  found  a  high  prevalence
of  sleep  disorders,  including  OSA,  in  people  with  epilepsy
(Beran  et  al.,  1999;  Marlow  et  al.,  2000,  2008;  Kader  et  al.,
2010).  While  snoring  was  associated  with  ACE  in  this  study,
we  cannot  extrapolate  any  temporal  relationship  or  etiolog-
ical  association  between  snoring  and  seizures.  Furthermore,
snoring  may  be  a  risk  factors  or  a  consequence  of  a  co-
morbid  condition,  such  as  sleep  apnea.  Additional  research
is  warranted  to  better  understand  this  unusual  ﬁnding.
Mother’s  experience  with  formal  education
In  individuals  <18  years  of  age,  having  a  mother  who
attended  some  formal  education  was  found  to  be  a  pro-
tective  factor,  which  differs  from  earlier  research  in  LMICs
(Hackett  et  al.,  1997;  Mung’ala-Odera  et  al.,  2008).  Edu-
cation  is  often  linked  with  higher  socio-economic  status,
which  in  turn  can  be  linked  with  better  access  to  healthcare.
Further  research  to  establish  the  temporality  and  causal
pathway  of  a  mother’s  education  as  a  protective  factor  for
her  child  developing  ACE  is  warranted.
Infections  known  to  be  associated  with  ACE
Toxocara,  toxoplasmosis,  HIV  and  malaria  were  not  sig-
niﬁcantly  associated  with  ACE  in  this  study,  which  differs
from  other  SEEDS  sites  (Ngugi  et  al.,  2013).  None  of  the
patients  with  ACE  had  evidence  of  exposure  to  neurocys-
ticercosis,  an  established  risk  factor  for  epilepsy  in  other
parts  of  Africa.  These  results  differ  markedly  from  the  East-
ern  Cape  province  of  South  Africa,  where  an  estimated
34,662  cases  (95%  CI:  17,167—54,068)  of  epilepsy  related  to
neurocysticercosis  occurred  in  2004  (Carabin  et  al.,  2006).
This  difference  is  likely  the  result  of  very  little  free-range
pig  farming  within  the  Agincourt  sub-district  and  regionally,
coupled  with  some  local  religions  forbidding  consumption  of
pork.
Human  immunodeﬁciency  virus  (HIV)
Surprisingly,  we  did  not  ﬁnd  HIV  infection  to  be  a  risk
factor  for  ACE,  even  though  the  prevalence  of  HIV  infec-
tion  in  this  area  is  high  (18%  of  cases  and  23%  of  controls
in  this  study)  (Gómez-Olivé  et  al.,  2013).  While  HIV  was
not  shown  to  be  a risk  factor  for  ACE,  studies  elsewhere
report  new-onset  seizures  to  be  associated  with  HIV  infec-
tion  and  subsequent  opportunistic  infections  (Satishchandra
and  Sinha,  2008).  HIV  was  furthermore  not  associated  with
adult  onset  epilepsy  nor  was  toxoplasmosis  associated  with
HIV  in  this  study.  Due  to  the  cross-sectional  design  of  this
study,  individuals  at  risk  for  epilepsy,  because  of  an  oppor-
tunistic  infection  due  to  HIV,  may  be  missed  due  to  early
mortality.  More  research  on  interactions  between  HIV  and
epilepsy  is  indicated,  particularly  in  the  absence  of  oppor-
tunistic  cerebral  infections.
Conclusion
This  study,  the  largest  population-based  epilepsy  study  in
rural  South  Africa  to-date,  found  convulsive  epilepsy  to  be
less  frequent  in  this  area  than  in  other  parts  of  SSA,  with
signiﬁcant  heterogeneity  between  villages.  The  lower  preva-
lence  levels  of  epilepsy  found  in  this  study  could  be  due  to
the  deﬁnition  of  epilepsy  used  in  this  study,  increased  access
to  professional  support  during  birth  leading  to  reduced
adverse  perinatal  events  or  lack  of  parasites.  More  than  half
of  all  patients  had  the  onset  of  seizures  within  the  ﬁrst  two
decades  of  life  and  risk  factors  include  a  family  history  of
seizures,  problems  during  delivery,  and  a  history  of  snoring.
HIV  was  not  found  to  be  a  risk  factor  for  developing  ACE.
Given  the  substantial  burden  of  epilepsy,  further  research
on  the  burden,  including  morbidity  and  mortality,  as  well  as
treatment  options  for  and  economic  burden  of  epilepsy  in
rural  SSA  is  warranted.
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